Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

28 August 2017 (15:40 - 15:50)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Jose Manuel Soria Fernandez

Sant Pau (Spain)

4 More presentations in this session

Presentation thumbnail

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Professor C. Christersson (Uppsala, SE)

Presentation thumbnail

Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Professor T. Heidt (Buhl, DE)

Presentation thumbnail

Systemic versus site targeted treatment of neoatherosclerosis.

Doctor M. Joner (Munich, DE)

Presentation thumbnail

Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Doctor D. Tregouet (Paris, FR)

Access the full session

Session thumbnail

ESC Grants for Medical Research Innovation

The Event

ESC Congress 2017

28 August 2017 15:40 CET

You may be interested in

Webinar

Cancer associated thrombosis: have DOACs changed daily practice?

21 September 2021

Congress Presentation

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

31 August 2019

Congress Presentation

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

28 August 2023

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

19 July 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources